Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 690

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 4
Chunk 690
---
 Backstop Agreement. These transactions were effected without
registration under the Securities Act in reliance on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

179

In
connection with the Closing of the Business Combination, on February 14, 2023, the registrant issued to Sponsor 1,365,000 shares of Aesther’s
Class A common stock in connection with Sponsor obtaining two (2) three-month extensions beyond the September 16, 2022 deadline to complete
an initial business combination. Such shares were reclassified as Ocean Biomedical Common Stock in connection with the Business Combination
pursuant to the Amended Certificate. These transactions were effected without registration under the Securities Act in reliance on the
exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Loan Modification Agreement, on March 22, 2023, we issued to NPIC Limited 50,000 shares of our Common Stock in exchange
for the extension of the maturity date of the loan made pursuant to the Loan and Transfer Agreement between the registrant, the Sponsor
and NPIC Limited dated December 13, 2022. These transactions were effected without registration under the Securities Act in reliance
on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Loan Modification Agreement, on April 19, 2023, we issued to NPIC Limited an additional 50,000 shares of our Common
Stock in exchange for the extension of the maturity date of the loan made pursuant to the Loan and Transfer Agreement between the registrant,
the Sponsor and NPIC Limited dated December 13, 2022. These transactions were effected without registration under the Securities Act
in reliance on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Loan Modification Agreement, on May 12, 2023, we issued to NPIC Limited an additional 50,000 shares of our Common
Stock in exchange for the extension of the maturity date of the loan made pursuant to the Loan and Transfer Agreement between the registrant,
the Sponsor and NPIC Limited dated December 13, 2022. These transactions were effected without registration under the Securities Act
in reliance on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Marketing Services Agreement, dated March 7